Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

USA - NASDAQ:OSUR - US68554V1089 - Common Stock

3.31 USD
-0.01 (-0.3%)
Last: 9/12/2025, 8:06:27 PM
3.34 USD
+0.03 (+0.91%)
After Hours: 9/12/2025, 8:06:27 PM
Fundamental Rating

2

OSUR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of OSUR is average, but there are quite some concerns on its profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OSUR has reported negative net income.
In the past year OSUR has reported a negative cash flow from operations.
In the past 5 years OSUR reported 4 times negative net income.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.47%, OSUR is in line with its industry, outperforming 59.47% of the companies in the same industry.
OSUR's Return On Equity of -13.40% is fine compared to the rest of the industry. OSUR outperforms 64.21% of its industry peers.
Industry RankSector Rank
ROA -11.47%
ROE -13.4%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

With a Gross Margin value of 40.49%, OSUR is not doing good in the industry: 66.84% of the companies in the same industry are doing better.
OSUR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSUR has been increased compared to 1 year ago.
Compared to 5 years ago, OSUR has more shares outstanding
The debt/assets ratio for OSUR has been reduced compared to a year ago.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.43 indicates that OSUR is not a great score, but indicates only limited risk for bankruptcy at the moment.
OSUR's Altman-Z score of 2.43 is fine compared to the rest of the industry. OSUR outperforms 66.32% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, OSUR is doing good in the industry, outperforming 73.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.43
ROIC/WACCN/A
WACC8.69%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

OSUR has a Current Ratio of 7.12. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OSUR (7.12) is better than 86.32% of its industry peers.
OSUR has a Quick Ratio of 6.33. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.33, OSUR belongs to the top of the industry, outperforming 86.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.12
Quick Ratio 6.33
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for OSUR have decreased strongly by -286.11% in the last year.
Looking at the last year, OSUR shows a very negative growth in Revenue. The Revenue has decreased by -49.36% in the last year.
OSUR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.75% yearly.
EPS 1Y (TTM)-286.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2500%
Revenue 1Y (TTM)-49.36%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-42.5%

3.2 Future

OSUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.37% yearly.
The Revenue is expected to decrease by -4.62% on average over the next years.
EPS Next Y-192.27%
EPS Next 2Y-31.38%
EPS Next 3Y-8.44%
EPS Next 5Y25.37%
Revenue Next Year-34.69%
Revenue Next 2Y-17.06%
Revenue Next 3Y-9.34%
Revenue Next 5Y-4.62%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A cheap valuation may be justified as OSUR's earnings are expected to decrease with -8.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-31.38%
EPS Next 3Y-8.44%

More info and screens

0

5. Dividend

5.1 Amount

OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (9/12/2025, 8:06:27 PM)

After market: 3.34 +0.03 (+0.91%)

3.31

-0.01 (-0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners91.78%
Inst Owner Change-0.3%
Ins Owners4.72%
Ins Owner Change8.12%
Market Cap242.09M
Analysts80
Price Target6.12 (84.89%)
Short Float %5.33%
Short Ratio5.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.39%
Min EPS beat(2)-24.34%
Max EPS beat(2)-0.43%
EPS beat(4)1
Avg EPS beat(4)-35.92%
Min EPS beat(4)-142.2%
Max EPS beat(4)23.28%
EPS beat(8)4
Avg EPS beat(8)-43.86%
EPS beat(12)8
Avg EPS beat(12)205%
EPS beat(16)8
Avg EPS beat(16)106.42%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)0.89%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)10.24%
Revenue beat(16)15
Avg Revenue beat(16)9.83%
PT rev (1m)0%
PT rev (3m)33.33%
EPS NQ rev (1m)-11.76%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.7%
Revenue NQ rev (1m)-14.71%
Revenue NQ rev (3m)-19.97%
Revenue NY rev (1m)-4.98%
Revenue NY rev (3m)-4.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.75
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.89
BVpS5.21
TBVpS4.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.47%
ROE -13.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.19%
Cap/Sales 2.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.12
Quick Ratio 6.33
Altman-Z 2.43
F-Score3
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-286.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2500%
EPS Next Y-192.27%
EPS Next 2Y-31.38%
EPS Next 3Y-8.44%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-49.36%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-42.5%
Revenue Next Year-34.69%
Revenue Next 2Y-17.06%
Revenue Next 3Y-9.34%
Revenue Next 5Y-4.62%
EBIT growth 1Y-528.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-70.51%
EBIT Next 3Y44.24%
EBIT Next 5Y25.91%
FCF growth 1Y-140.24%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-127.86%
OCF growth 3YN/A
OCF growth 5Y22.81%